EQT Healthcare Growth to acquire Europa Biosite, a distributor of over ten million high-quality life science reagents to academic and biopharma researchers across Europe and North America, from Adelis ...

SAN DIEGO and BRUSSELS, Belgium – Biosite Incorporated (Nasdaq:BSTE) today announced preliminary results of a sample collection study aimed at identifying a biomarker panel that could potentially aid ...

ASSA ABLOY AB ASAZY announced that it acquired Solihull, U.K.-based Biosite Systems. The financial details of the transaction have been kept under wraps. It is worth mentioning here that the company’s ...

Beckman Coulter, which makes products for biomedical tests, said on Sunday it would acquire Biosite for about $1.55 billion to expand its presence in the market for diagnosis and assessment of heart ...

Good morning, Nina Lindholm here with the Europe Wire from the London newsroom. Europe could become the place to be for life sciences in the near future. EQT is betting on that possibility, and this ...

Kim D. Blickenstaff and company have rescued Biosite from cash shortages and skeptics of every variety. He hasn't fought off the last of the short-sellers. Kim D. Blickenstaff dwells among ...

Children often imagine science as something done in laboratories by people wearing sparkling white coats and staring down microscopes. But at the age of nine, Allyson Landreth, learned that she could ...

Strategic rationale and economics of combination support increased price of $90 per Biosite share. Beckman Coulter has rivaled Inverness Medical Innovations’ acquisition price for Biosite. The company ...

Inverness Medical Innovations says it has made a $90 a share cash offer for Biosite that is "superior" to a buyout deal already accepted from Beckman Coulter. Beckman said last month it would acquire ...

Every Thursday morning, about 50 fourth-graders from Horace Mann Elementary School head to Downtown College Prep to work in the high school’s garden, planting seedlings, feeding chickens and learning ...

NEW YORK (MarketWatch) -- Inverness Medical Innovations Inc. has confirmed its proposal to acquire BioSite Inc. for $90 per share in cash. The company said it expects the acquisition would immediately ...